4//SEC Filing
MURPHY ANDREW J 4
Accession 0001968202-24-000119
CIK 0000872589other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:01 PM ET
Size
40.4 KB
Accession
0001968202-24-000119
Insider Transaction Report
Form 4
MURPHY ANDREW J
EVP Research
Transactions
- Sale
Common Stock
2024-08-14$1148.52/sh−537$616,755→ 53,706 total - Sale
Common Stock
2024-08-14$1153.74/sh−987$1,138,741→ 51,199 total - Sale
Common Stock
2024-08-14$1142.94/sh−48$54,861→ 54,566 total - Exercise/Conversion
Common Stock
2024-08-13$399.66/sh+20,000$7,993,200→ 68,306 total - Sale
Common Stock
2024-08-14$1140.31/sh−55$62,717→ 54,614 total - Sale
Common Stock
2024-08-14$1156.43/sh−1,016$1,174,933→ 49,004 total - Sale
Common Stock
2024-08-14$1143.28/sh−79$90,319→ 54,487 total - Sale
Common Stock
2024-08-14$1146.60/sh−51$58,477→ 54,243 total - Sale
Common Stock
2024-08-14$1149.60/sh−294$337,982→ 53,412 total - Sale
Common Stock
2024-08-14$1150.41/sh−844$970,946→ 52,568 total - Sale
Common Stock
2024-08-14$1152.36/sh−197$227,015→ 52,186 total - Sale
Common Stock
2024-08-14$1154.66/sh−777$897,171→ 50,422 total - Sale
Common Stock
2024-08-14$1155.76/sh−402$464,616→ 50,020 total - Sale
Common Stock
2024-08-14$1158.78/sh−189$219,009→ 48,637 total - Sale
Common Stock
2024-08-14$1157.41/sh−178$206,019→ 48,826 total - Sale
Common Stock
2024-08-14$1159.69/sh−331$383,857→ 48,306 total - Tax Payment
Common Stock
2024-08-13$1141.49/sh−13,637$15,566,499→ 54,669 total - Sale
Common Stock
2024-08-14$1144.89/sh−45$51,520→ 54,442 total - Sale
Common Stock
2024-08-14$1145.58/sh−148$169,546→ 54,294 total - Sale
Common Stock
2024-08-14$1151.46/sh−185$213,020→ 52,383 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-08-13−20,000→ 0 totalExercise: $399.66Exp: 2024-12-16→ Common Stock (20,000 underlying)
Holdings
- 4,326(indirect: By 401(k))
Common Stock
Footnotes (15)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
- [F10]Represents volume-weighted average price of sales of 402 shares of Company stock on August 14, 2024 at prices ranging from $1,155.04 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 1,016 shares of Company stock on August 14, 2024 at prices ranging from $1,156.06 to $1,156.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 178 shares of Company stock on August 14, 2024 at prices ranging from $1,157.13 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 189 shares of Company stock on August 14, 2024 at prices ranging from $1,158.53 to $1,158.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F14]Represents volume-weighted average price of sales of 331 shares of Company stock on August 14, 2024 at prices ranging from $1,159.21 to $1,159.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F15]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
- [F2]Represents volume-weighted average price of sales of 148 shares of Company stock on August 14, 2024 at prices ranging from $1,145.33 to $1,145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 537 shares of Company stock on August 14, 2024 at prices ranging from $1,148.06 to $1,148.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 294 shares of Company stock on August 14, 2024 at prices ranging from $1,149.13 to $1,149.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 844 shares of Company stock on August 14, 2024 at prices ranging from $1,150.10 to $1,150.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 185 shares of Company stock on August 14, 2024 at prices ranging from $1,151.09 to $1,151.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 197 shares of Company stock on August 14, 2024 at prices ranging from $1,152.27 to $1,152.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 987 shares of Company stock on August 14, 2024 at prices ranging from $1,153.07 to $1,153.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 777 shares of Company stock on August 14, 2024 at prices ranging from $1,154.05 to $1,154.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 14, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001796226
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:01 PM ET
- Size
- 40.4 KB